Oxeladin Citrate
Get a Quick Quote Now
Select Packaging
Product Description
Product
Oxeladin Citrate
CAS
52432-72-1
Formula
C26H41NO10
Synonym
2-hydroxypropane-1,2,3-tricarboxylic acid, 2-(2-(Diethylamino)ethoxy)ethyl 2-ethyl-2-phenylbutanoate 2-hydroxypropane-1,2,3-tricarboxylate, Oxeladinecitrate, Oxeladindihydrogencitrat, OXELADIN CITRATE [MI], SCHEMBL405412, CHEMBL2354637, DTXCID2026608, OXELADIN CITRATE [MART.], OXELADIN CITRATE [WHO-DD], HMS3264M05, Pharmakon1600-01505774, BCP32879, CCA43272, HY-B1216, Tox21_112419, NSC759231, s4402, AKOS016033565, CCG-213984, CS-4842, BS-17215, Oxeladin citrate salt, analytical standard, CAS-52432-72-1, DB-052121, FT-0640068, D01576, E75909, Oxeladin citrate salt; oxeladin citrate, 52432-72-1, Oxeladin (citrate), Oxeladin citrate salt, Oxeladin citrate [JAN], Oxeladin Hydrogen Citrate, DTXSID4046608, NSC-759231, Oxeladin citrate (JAN), 2-[2-(diethylamino)ethoxy]ethyl 2-ethyl-2-phenylbutanoate; Oxeladin Hydrogen Citrate, OXELADIN HYDROGEN CITRATE [EP MONOGRAPH], SR-01000773049, 2-(2-Diethylaminoethoxy)ethyl ,-diethylphenylacetate, SR-01000773049-2, Q27261748, Oxeladin hydrogen citrate, European Pharmacopoeia (EP) Reference Standard, 2-(2-DIETHYLAMINOETHOXY)ETHYL 2-ETHYL-2-PHENYLBUTYRATE DIHYDROGEN CITRATE, 2-(2-(Diethylamino)ethoxy)ethyl2-ethyl-2-phenylbutanoate2-hydroxypropane-1,2,3-tricarboxylate, BENZENEACETIC ACID, .ALPHA.,.ALPHA.-DIETHYL-, 2-(2-(DIETHYLAMINO)ETHOXY)ETHYL ESTER, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)
Typical Product Specifications
Chemical Structure
Assay/Purity
Typically NLT 98%
Notes
Oxeladin Citrate is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
Oxeladin Citrate
Product Description
Product
Oxeladin Citrate
CAS
52432-72-1
Formula
C26H41NO10
Synonym
2-hydroxypropane-1,2,3-tricarboxylic acid, 2-(2-(Diethylamino)ethoxy)ethyl 2-ethyl-2-phenylbutanoate 2-hydroxypropane-1,2,3-tricarboxylate, Oxeladinecitrate, Oxeladindihydrogencitrat, OXELADIN CITRATE [MI], SCHEMBL405412, CHEMBL2354637, DTXCID2026608, OXELADIN CITRATE [MART.], OXELADIN CITRATE [WHO-DD], HMS3264M05, Pharmakon1600-01505774, BCP32879, CCA43272, HY-B1216, Tox21_112419, NSC759231, s4402, AKOS016033565, CCG-213984, CS-4842, BS-17215, Oxeladin citrate salt, analytical standard, CAS-52432-72-1, DB-052121, FT-0640068, D01576, E75909, Oxeladin citrate salt; oxeladin citrate, 52432-72-1, Oxeladin (citrate), Oxeladin citrate salt, Oxeladin citrate [JAN], Oxeladin Hydrogen Citrate, DTXSID4046608, NSC-759231, Oxeladin citrate (JAN), 2-[2-(diethylamino)ethoxy]ethyl 2-ethyl-2-phenylbutanoate; Oxeladin Hydrogen Citrate, OXELADIN HYDROGEN CITRATE [EP MONOGRAPH], SR-01000773049, 2-(2-Diethylaminoethoxy)ethyl ,-diethylphenylacetate, SR-01000773049-2, Q27261748, Oxeladin hydrogen citrate, European Pharmacopoeia (EP) Reference Standard, 2-(2-DIETHYLAMINOETHOXY)ETHYL 2-ETHYL-2-PHENYLBUTYRATE DIHYDROGEN CITRATE, 2-(2-(Diethylamino)ethoxy)ethyl2-ethyl-2-phenylbutanoate2-hydroxypropane-1,2,3-tricarboxylate, BENZENEACETIC ACID, .ALPHA.,.ALPHA.-DIETHYL-, 2-(2-(DIETHYLAMINO)ETHOXY)ETHYL ESTER, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)
Typical Product Specifications
Chemical Structure
Assay/Purity
Typically NLT 98%
Notes
Oxeladin Citrate is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
